All In Biotech

Drug Trial Radar · NCT01552915

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Dose-optimization Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Last checked: Nov 20, 2026Latest source record: Jun 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 464 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

464

Actual

Start

Apr 17, 2012

Primary completion

Jan 22, 2014

Study completion Jan 22, 2014

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Mar 13, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 13 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).

Conditions

  • Attention-deficit/Hyperactivity Disorder

Interventions

  • Lisdexamfetamine dimesylateDrug

    Daily oral dosing in the AM of optimized dose, ranging from 30- 70 mg. 5 week dose optimization, 3 week dose maintenance

  • Methylphenidate HydrochlorideDrug

    Daily oral dosing in the AM of optimized dose, ranging from 18-72 mg. 5 week dose optimization, 3 week dose maintenance

  • PlaceboDrug

    Daily oral dosing in the AM for 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 8Time frame: Baseline and week 8

Locations

79 sites in 1 country. Site status is shown where the registry gives one.

  • Melmed Center

    Scottsdale, Arizona

  • Clinical Study Centers, LLC

    Little Rock, Arkansas

  • Synergy Clinical Research Center

    National City, California

  • Pacific Clinical Research Medical Group

    Orange, California

  • SDS Clinical Trials, Inc.

    Orange, California

  • Peninsula Research Associates, Inc.

    Rolling Hills Estates, California

  • PCSD - Feighner Research

    San Diego, California

  • University of California, San Francisco

    San Francisco, California

  • Neuropsychiatric Research Center of Orange County

    Santa Ana, California

  • Elite Clinical Trials

    Wildomar, California

  • MCB Clinical Research Centers, LLC

    Colorado Springs, Colorado

  • Florida Clinical Research Center, LLC

    Bradenton, Florida

  • Sarkis Clinical Trials

    Gainesville, Florida

  • Amedica Research Institute

    Hialeah, Florida

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Fidelity Clinical Research, Inc.

    Lauderhill, Florida

  • Florida Clinical Research Center, LLC

    Maitland, Florida

  • Scientific Clinical Research, Inc.

    Miami, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Compass Research, LLC

    Orlando, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • Janus Center for Psychiatric Research

    West Palm Beach, Florida

  • Atlanta Institute of Medicine and Research

    Atlanta, Georgia

  • Capstone Clinical Research

    Libertyville, Illinois

  • AMR Baber Research Group, Inc.

    Naperville, Illinois

  • AMR Conventions Research

    Naperville, Illinois

  • American Medical Research, Inc

    Oak Brook, Illinois

  • Advocate Hope Children's Hospital

    Oak Lawn, Illinois

  • Neuroscience Research Institute, Inc

    Oak Park, Illinois

  • Psychiatric Associates

    Overland Park, Kansas

  • University of Kentucky

    Lexington, Kentucky

  • Four Rivers Clinical Research

    Paducah, Kentucky

  • Neuroscientific InSights

    Rockville, Maryland

  • Marc Hertzman MD, PC

    Rockville, Maryland

  • Rochester Center for Behavioral Medicine

    Rochester Hills, Michigan

  • Clinical Neurophysiology Services, PC

    Sterling Heights, Michigan

  • Behavioral Medical Center - Troy

    Troy, Michigan

  • Precise Research Centers

    Flowood, Mississippi

  • Comprehensive Psychiatric Associates

    Gladstone, Missouri

  • St Charles Psychiatric Associates

    Saint Charles, Missouri

Showing 40 of 79 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.